MENU
+Compare
AKYA
Stock ticker: NASDAQ
AS OF
Jan 31, 10:40 AM (EDT)
Price
$3.02
Change
+$0.03 (+1.00%)
Capitalization
230.47M

AKYA Akoya BioSciences Forecast, Technical & Fundamental Analysis

AKYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for AKYA with price predictions
Jan 29, 2025

AKYA in upward trend: 10-day moving average broke above 50-day moving average on January 13, 2025

The 10-day moving average for AKYA crossed bullishly above the 50-day moving average on January 13, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 11 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on January 07, 2025. You may want to consider a long position or call options on AKYA as a result. In of 74 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

AKYA moved above its 50-day moving average on January 07, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where AKYA advanced for three days, in of 186 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 93 cases where AKYA Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for AKYA moved out of overbought territory on January 24, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 14 similar instances where the indicator moved out of overbought territory. In of the 14 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 41 cases where AKYA's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

AKYA broke above its upper Bollinger Band on January 07, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. AKYA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.167) is normal, around the industry mean (23.424). P/E Ratio (0.000) is within average values for comparable stocks, (83.627). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (2.097) is also within normal values, averaging (41.167).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AKYA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.

View a ticker or compare two or three
AKYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

AKYA is expected to report earnings to fall 25.57% to -15 cents per share on March 10

Akoya BioSciences AKYA Stock Earnings Reports
Q4'24
Est.
$-0.16
Q3'24
Missed
by $0.01
Q2'24
Est.
$-0.27
Q1'24
Missed
by $0.19
Q4'23
Beat
by $0.05
The last earnings report on November 14 showed earnings per share of -20 cents, missing the estimate of -20 cents. With 1.48K shares outstanding, the current market capitalization sits at 230.47M.
A.I. Advisor
published General Information

General Information

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
N/A
Address
100 Campus Drive
Phone
+1 855 896-8401
Employees
330
Web
https://www.akoyabio.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GSRIX12.66N/A
N/A
Goldman Sachs Rising Dividend Gr Inv
JEMQX9.48N/A
N/A
JHancock Emerging Markets Equity A
FERGX13.68N/A
N/A
Fidelity SAI Emerging Markets Index
MAIJX16.26N/A
N/A
Morgan Stanley Inst Passport ovrs eq R6
VKSFX10.67N/A
N/A
Virtus KAR Small-Mid Cap Value I

AKYA and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, AKYA has been loosely correlated with MXCT. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if AKYA jumps, then MXCT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AKYA
1D Price
Change %
AKYA100%
-0.33%
MXCT - AKYA
36%
Loosely correlated
-1.08%
NOTV - AKYA
32%
Poorly correlated
+1.59%
AXGN - AKYA
31%
Poorly correlated
-0.22%
IRMD - AKYA
29%
Poorly correlated
+0.77%
VMD - AKYA
29%
Poorly correlated
+0.36%
More